Venous or arterial samples for activated clotting time measurements: a systematic review

被引:1
|
作者
Iddawela, Sashini [1 ]
Swamy, Priti [2 ]
Member, Sajid [3 ]
Harky, Amer [4 ,5 ,6 ,7 ,8 ]
机构
[1] Univ Hosp Birmingham, Dept Resp Med, Birmingham, W Midlands, England
[2] Kings Coll London, GKT Sch Med Educ, London, England
[3] Univ Cent Lancashire, Lancashire Sch Med & Dent, Greenbank Bldg, Preston, Lancs, England
[4] Liverpool Heart & Chest Hosp, Dept Cardiothorac Surg, Thomas Dr, Liverpool L14 3PE, Merseyside, England
[5] Univ Liverpool, Fac Hlth & Iife Sci, Dept Integrat Biol, Liverpool, Merseyside, England
[6] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[7] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[8] Alder Hey Children Hosp, Dept Cardiac Surg, Liverpool, Merseyside, England
来源
PERFUSION-UK | 2021年 / 36卷 / 08期
关键词
clotting factors; ACT; venous; arterial; cardiac surgery; cardiac catheterisation; COAGULATION TIME; HEPARIN; THROMBOELASTOGRAPHY; SURGERY;
D O I
10.1177/0267659120967836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The systematic review aims to investigate the effect of sampling source on activated clotting time (ACT) measurement within cardiovascular surgery and cardiac catheterisation. It also examines the evidence surrounding novel clot assessment techniques and associated sampling variation. Methods: A comprehensive electronic search was conducted using PubMed, MEDLINE, Scopus, Cochrane database, and Google Scholar until 20th June 2020. All studies reporting sampling source variability of ACT in cardiac surgery, vascular surgery and cardiac catheterisation were included. Results: Fourteen studies were included in the systematic review. Inconsistent reports of variability were seen in cardiac surgery and cardiac catheterisation. There were no studies directly examining ACT variability in vascular surgery. Novel clot assessment techniques have been validated in cardiac surgery, but measurements vary depending on sampling source. Conclusion: Sampling source should be kept consistent to facilitate effective haemostatic strategies. More research is needed regarding variability in vascular surgery and novel clot assessment techniques.
引用
收藏
页码:845 / 852
页数:8
相关论文
共 50 条
  • [1] A comparison between arterial- and venous-sampled activated clotting time measurements
    Zisman, E
    Rozenberg, B
    Katz, Y
    Ziser, A
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1997, 33 (12): : 786 - 788
  • [2] Percutaneous transluminal coronary angioplasty: Comparison of arterial vs Venous activated clotting time
    Pesola, GR
    Johnson, A
    Pesola, DA
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1996, 37 (02): : 140 - 144
  • [3] Activated clotting time measurements and aprotinin studies
    Abramson, DC
    Pivalizza, EG
    Gottschalk, LI
    CIRCULATION, 1996, 94 (07) : 1791 - 1792
  • [4] The truth about activated clotting time measurements
    Bittl, JA
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 65 (03) : 338 - 339
  • [5] Activated clotting time measurements and aprotinin studies - Response
    Levy, JH
    CIRCULATION, 1996, 94 (07) : 1792 - 1792
  • [6] Venous activated clotting time after intra-arterial heparin: Effect of site of administration and timing of sampling
    Kerensky, RA
    Azar, GJ
    Bertolet, B
    Hill, JA
    Kutcher, MA
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1996, 37 (02): : 151 - 153
  • [7] Ability of Activated Clotting Time Measurements to Monitor Unfractionated Heparin Activity During NonCardiac Arterial Procedures
    Hoebink, Max
    Steunenberg, Thomas A. H.
    Roosendaal, Liliane C.
    Wiersema, Arno M.
    Hamer, Henrike M.
    Yeung, Kak Khee
    Jongkind, Vincent
    ANNALS OF VASCULAR SURGERY, 2025, 110 : 460 - 468
  • [8] ACT (ACTIVATED CLOTTING TIME) DETERMINATION IN VASCULAR SHEATHS - ARE ACT VALUES DIFFERENT BETWEEN ARTERIAL AND VENOUS SAMPLES AFTER HEPARIN FLUSH OR HEPARIN BOLUS ADMINISTRATION
    FARRAR, JR
    STEIN, J
    FRIEDMAN, R
    RUDZIK, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A376 - A376
  • [9] A comparison of arterial versus venous-activated clotting time in patients with congenital heart disease undergoing cardiac catheterization
    Zeevi, B
    Bar-Mor, G
    Livne, M
    Berant, M
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 1999, 46 (02) : 194 - 196
  • [10] Reproducibility and variability of activated clotting time measurements in the cardiac catheterization laboratory
    Doherty, TM
    Shavelle, RM
    French, WJ
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 65 (03) : 330 - 337